Post-trade Moderna position: 500,000 shares, valued at $12.91 million Moderna now accounts for 1.23% of Telemark’s reportable AUM, which places it outside the fund’s top five holdings According to a ...
Moderna, Inc. is a biotechnology company specializing in the discovery and development of mRNA-based medicines. The company leverages its mRNA technology platform to address a broad range of diseases, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback